CRDL Cardiol Therapeutics Inc.
Healthcare$1.30-1.52%ClosedMarket Cap: $145.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
8.33
P/S
0.00
EV/EBITDA
-5.09
DCF Value
$0.18
FCF Yield
-11.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-229.2%
ROA
-115.7%
ROIC
-146.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-9.7M | $-10.8M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-8.0M | $-7.2M | $— | — |
| FY null | $0.00 | NaN% | $-34.3M | $-33.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-10.2M | $-10.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-7.7M | $-8.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-8.4M | $-8.3M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-6.9M | $-5.7M | $— | — |
| FY null | $0.00 | NaN% | $-40.3M | $-36.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-14.1M | $-12.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-5.7M | $-4.8M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-8.4M | $-9.2M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-6.1M | $-5.8M | $-0.12 | — |